The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran.

BACKGROUND The objective of this study was to determine the upper normal limit of serum alanine aminotransferase level in a population-based study in Golestan Province, northeast Iran. METHODS From the randomly invited individuals (2,292), 698 out of the 916 males and 1,351 out of the 1,376 females participated in the study (participation rate: 76.2% and 98.1%, respectively). One hundred and twenty-one participants were excluded due to positive hepatitis B surface antigen or hepatitis C virus antibody and/or drinking more than 20 grams of alcohol per day. A total of 1,928 participants (1300 females) were included. The upper normal limit of serum alanine aminotransferase level was defined as the 95th percentile. RESULTS The upper normal limit of serum alanine aminotransferase level in normal weight and nondiabetics was significantly lower than the total study group (36 versus 45 U/L). Serum alanine aminotransferase level was independently associated with male gender, body mass index, and diabetes mellitus (OR=2.05; 95%CI: 1.44 - 2.94, OR=2.76; 95%CI: 1.84 - 4.13, and OR=2.96; 95%CI: 1.56 - 5.61, respectively). CONCLUSION Considering the lower calculated upper normal limit in normal weight nondiabetic participants in this study, we recommend setting new upper normal limit for serum alanine aminotransferase level. It seems reasonable to set upper normal limit for serum alanine aminotransferase level in males and females separately.

[1]  Anwar Batieha,et al.  An increase in prevalence of diabetes mellitus in Jordan over 10 years. , 2008, Journal of diabetes and its complications.

[2]  A. Pourshams,et al.  Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. , 2008, World journal of gastroenterology.

[3]  A. Moschetta,et al.  Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  R. Malekzadeh,et al.  Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women , 2006, BMC public health.

[5]  M. Leshno,et al.  Re‐evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large‐scale population study , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[6]  K. Choi,et al.  Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. , 2006, Diabetes care.

[7]  H. Ueshima,et al.  The Value of Combining Serum Alanine Aminotransferase Levels and Body Mass Index to Predict Mortality and Medical Costs: a 10-year Follow-up Study of National Health Insurance in Shiga, Japan , 2005, Journal of epidemiology.

[8]  A. Moschetta,et al.  Normal serum alanine aminotransferase activity in uncomplicated obesity. , 2005, World journal of gastroenterology.

[9]  T. Tung,et al.  A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. , 2005, World journal of gastroenterology.

[10]  R. Malekzadeh,et al.  Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors , 2005, Journal of gastroenterology and hepatology.

[11]  Tao-HsinTung,et al.  A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan , 2005 .

[12]  R. Malekzadeh,et al.  OBESITY PANDEMIC: AN IRANIAN PERSPECTIVE , 2005 .

[13]  I. Suh,et al.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.

[14]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[15]  R. Malekzadeh,et al.  Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. , 2003, World journal of gastroenterology.

[16]  J. Choi.  Association between elevated serum hepatic enzyme activity and total body fat in obese humans. , 2003, Annals of clinical and laboratory science.

[17]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.

[18]  D. Christiani,et al.  Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study. , 2001, International journal of epidemiology.

[19]  M. Kaplan,et al.  Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.

[20]  T. Ben-Menachem,et al.  Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients , 1999, American Journal of Gastroenterology.

[21]  J. Delattre,et al.  Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C , 1998, Hepatology.

[22]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[23]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. , 1998, WMJ : official publication of the State Medical Society of Wisconsin.

[24]  M. Lozano,et al.  Study of serum alanine-aminotransferase levels in blood donors in Spain. , 1998, Haematologica.

[25]  N. Bashardoost,et al.  Prevalence and risk factors of diabetes mellitus in the Isfahan city population (aged 40 or over) in 1993. , 1997, Diabetes research and clinical practice.

[26]  F. Gordon,et al.  Nonalcoholic Steatohepatitis: Reply , 1997, Annals of Internal Medicine.

[27]  J. Krüger,et al.  [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors]. , 1995, Infusionstherapie und Transfusionsmedizin.

[28]  A. Salvaggio,et al.  Body mass index and liver enzyme activity in serum. , 1991, Clinical chemistry.

[29]  J. Ludwig,et al.  The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients , 1989, Hepatology.

[30]  W. V. Miller,et al.  The distribution of serum alanine aminotransferase levels in a blood donor population. , 1982, American journal of epidemiology.

[31]  L. Kállai,et al.  CORRELATION BETWEEN HISTOLOGICAL FINDINGS AND SERUM TRANSAMINASE VALUES IN CHRONIC DISEASES OF THE LIVER. , 2009 .

[32]  M. Filotico,et al.  [Relation between transaminase activity of the blood & histological picture of the liver in human hepatic pathology]. , 1958, Minerva Medica.

[33]  A. Karmen,et al.  Transaminase activity in human blood. , 1955, The Journal of clinical investigation.